Liang Y, Guo J, Li Z, Liu S, Zhang T, Sun S
    
    
    Biosaf Health. 2025; 6(3):178-185.
  
  
    PMID: 40078727
    
          PMC: 11895015.
    
          DOI: 10.1016/j.bsheal.2024.04.002.
      
 
                                  
  
    Sanchez-Gaona N, Perea D, Curran A, Burgos J, Navarro J, Suanzes P
    
    
    Commun Biol. 2025; 8(1):236.
  
  
    PMID: 39953264
    
          PMC: 11829058.
    
          DOI: 10.1038/s42003-025-07651-6.
      
 
                                  
  
    Rahman M, Bissa M, Scinto H, Howe S, Sarkis S, Ma Z
    
    
    Nat Commun. 2024; 15(1):9102.
  
  
    PMID: 39438480
    
          PMC: 11496677.
    
          DOI: 10.1038/s41467-024-53359-2.
      
 
                                  
  
    Yucha R, Litchford M, Fish C, Yaffe Z, Richardson B, Maleche-Obimbo E
    
    
    Viruses. 2023; 15(10).
  
  
    PMID: 37896832
    
          PMC: 10611199.
    
          DOI: 10.3390/v15102055.
      
 
                                  
  
    Grunst M, Ladd R, Clark N, Gil H, Klenchin V, Mason R
    
    
    PLoS Pathog. 2023; 19(5):e1011407.
  
  
    PMID: 37253062
    
          PMC: 10256149.
    
          DOI: 10.1371/journal.ppat.1011407.
      
 
                              
              
                              
                                      
  Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother.
  
    Yaffe Z, Ding S, Sung K, Chohan V, Marchitto L, Doepker L
    
    
    iScience. 2023; 26(5):106762.
  
  
    PMID: 37216090
    
          PMC: 10196594.
    
          DOI: 10.1016/j.isci.2023.106762.
      
 
                                          
                                                          
  Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes.
  
    Fornara C, Schultz E, Lilleri D, Baldanti F, Ryckman B, Gerna G
    
    
    Int J Mol Sci. 2023; 24(5).
  
  
    PMID: 36901847
    
          PMC: 10003051.
    
          DOI: 10.3390/ijms24054417.
      
 
                                          
                                                          
  Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.
  
    Mattathil J, Volz A, Onabajo O, Maynard S, Bixler S, Shen X
    
    
    Nat Commun. 2023; 14(1):1264.
  
  
    PMID: 36882405
    
          PMC: 9990026.
    
          DOI: 10.1038/s41467-023-36907-0.
      
 
                                          
                                                          
  Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection.
  
    Zhang A, Stacey H, DAgostino M, Tugg Y, Marzok A, Miller M
    
    
    Nat Rev Immunol. 2022; 23(6):381-396.
  
  
    PMID: 36536068
    
          PMC: 9761659.
    
          DOI: 10.1038/s41577-022-00813-1.
      
 
                                          
                                                          
  Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.
  
    Xu S, Carpenter M, Spreng R, Neidich S, Sarkar S, Tenney D
    
    
    NPJ Vaccines. 2022; 7(1):90.
  
  
    PMID: 35927399
    
          PMC: 9352797.
    
          DOI: 10.1038/s41541-022-00514-9.
      
 
                                          
                                                          
  Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.
  
    Bernard N, Kant S, Kiani Z, Tremblay C, Dupuy F
    
    
    Front Immunol. 2022; 13:879124.
  
  
    PMID: 35720328
    
          PMC: 9205404.
    
          DOI: 10.3389/fimmu.2022.879124.
      
 
                                          
                                                          
  Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
  
    Hong Y, Guo H, Wei M, Zhang Y, Fang M, Cheng T
    
    
    J Virol Methods. 2022; 307:114564.
  
  
    PMID: 35671888
    
          PMC: 9167684.
    
          DOI: 10.1016/j.jviromet.2022.114564.
      
 
                                          
                                                          
  Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response.
  
    Astorga-Gamaza A, Grau-Exposito J, Burgos J, Navarro J, Curran A, Planas B
    
    
    Elife. 2022; 11.
  
  
    PMID: 35616530
    
          PMC: 9177146.
    
          DOI: 10.7554/eLife.78294.
      
 
                                          
                                                          
  Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2.
  
    Natarajan H, Xu S, Crowley A, Butler S, Weiner J, Bloch E
    
    
    BMC Immunol. 2022; 23(1):7.
  
  
    PMID: 35172720
    
          PMC: 8851712.
    
          DOI: 10.1186/s12865-022-00480-w.
      
 
                                          
                                                          
  Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
  
    Adeniji O, Kuri-Cervantes L, Yu C, Xu Z, Ho M, Chew G
    
    
    PLoS Pathog. 2021; 17(11):e1010034.
  
  
    PMID: 34762717
    
          PMC: 8584986.
    
          DOI: 10.1371/journal.ppat.1010034.
      
 
                                          
                                                          
  Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
  
    Cheng H, Dowell K, Bailey-Kellogg C, Goods B, Love J, Ferrari G
    
    
    Retrovirology. 2021; 18(1):35.
  
  
    PMID: 34717659
    
          PMC: 8557579.
    
          DOI: 10.1186/s12977-021-00579-9.
      
 
                                          
                                                          
  TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure.
  
    Hvilsom C, Sogaard O
    
    
    Front Immunol. 2021; 12:704617.
  
  
    PMID: 34630386
    
          PMC: 8495198.
    
          DOI: 10.3389/fimmu.2021.704617.
      
 
                                          
                                                          
  Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection.
  
    Gunn B, Bai S
    
    
    Hum Vaccin Immunother. 2021; 17(11):4328-4344.
  
  
    PMID: 34613865
    
          PMC: 8827636.
    
          DOI: 10.1080/21645515.2021.1976580.
      
 
                                          
                                                          
  Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.
  
    Nagel L, Kant S, Leeks C, Routy J, Tremblay C, Thomas R
    
    
    J Virol. 2021; 95(24):e0162521.
  
  
    PMID: 34586863
    
          PMC: 8610575.
    
          DOI: 10.1128/JVI.01625-21.
      
 
                                          
                                                          
  Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2.
  
    Natarajan H, Xu S, Crowley A, Butler S, Weiner J, Bloch E
    
    
    medRxiv. 2021; .
  
  
    PMID: 34401890
    
          PMC: 8366811.
    
          DOI: 10.1101/2021.08.06.21261710.